From 3rd to 6th of November, PlumStars will participate at AAPS 2019 AAPS, an annual Conference of the American Association of Pharmaceutical Scientists that will be held at Henry B. González Convention Center, San Antonio, TX, USA.
There will be pitching,
demonstrations and great presentations, with take-aways for both investors and
innovation driven organizations.
Prof. Paolo Colombo (PlumeStars
CEO) will present two different speeches:
- “Hyaluronic-Cisplatin Film for Implant for
Malignant Mesothelioma Recurrences”.
- “Flurbiprofen powders for nose-to-brain
delivery as alzheimer’s disease modifying agent”.
The first speech concerns Hyalcis
exploits nanotechnology and advanced material research results to bring to
market an innovative medical treatment of mesothelioma. The studies until now
conducted revealed an interaction between the polymer hyaluronic acid and
cisplatin that gave rise to a drug-polymer complex, lymphatically absorbed and
blood distributed.
The uptake by pharmaceutical
industry of the hyaluronic- cisplatin film technology studied by PlumeStars
will assign a more effective cure against recurrences of this rare and very
aggressive form of cancer that is difficult to diagnose and highly resistant to
anticancer drugs.
Dr. Eride Quarta (PharmD; PhD
Student, PlumeStars Research Leader) will present:
- “Novel Insulin Powder: bioavalability in
rats”.
AAPS PharmSci 360 combines all
the energy of a large scientific conference with the intimacy of a niche
meeting.
Five robust tracks covering all
aspects of the pharmaceutical sciences, hundreds of exhibitors with dozens of
additional learning opportunities, thousands of scientific posters featuring
the latest, most innovative research in the field.